H A Fuchs1, T Pincus. 1. Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2681.
Abstract
OBJECTIVE: To determine if quantitative assessment of a reduced number of joints provides information equivalent to that obtained by the traditional 60-joint evaluation in detecting changes in patients participating in clinical trials of rheumatoid arthritis (RA). METHODS: The changes in quantitative joint scores of patients from 3 previously reported clinical trials were compiled and compared with changes in quantitative scores derived using a reduced number of joints. Effect sizes were calculated (mean change in joint score/standard deviation of joint score) and compared for the different joint indices. RESULTS: The effect sizes of the joint scores derived using a reduced number of joints were similar to those of the original 60-joint score. The reduced joint count scores revealed significant changes for clinical trials involving as few as 15 patients. CONCLUSION: Reduced joint count scores may be used to evaluate the results of clinical trials without decreasing the ability to detect change over time. Quantitative assessment of a reduced number of joints may also facilitate assessment of responses to treatment in the routine care of patients with RA.
OBJECTIVE: To determine if quantitative assessment of a reduced number of joints provides information equivalent to that obtained by the traditional 60-joint evaluation in detecting changes in patients participating in clinical trials of rheumatoid arthritis (RA). METHODS: The changes in quantitative joint scores of patients from 3 previously reported clinical trials were compiled and compared with changes in quantitative scores derived using a reduced number of joints. Effect sizes were calculated (mean change in joint score/standard deviation of joint score) and compared for the different joint indices. RESULTS: The effect sizes of the joint scores derived using a reduced number of joints were similar to those of the original 60-joint score. The reduced joint count scores revealed significant changes for clinical trials involving as few as 15 patients. CONCLUSION: Reduced joint count scores may be used to evaluate the results of clinical trials without decreasing the ability to detect change over time. Quantitative assessment of a reduced number of joints may also facilitate assessment of responses to treatment in the routine care of patients with RA.
Authors: Tamara J Somers; Rebecca A Shelby; Francis J Keefe; Neha Godiwala; Mark A Lumley; Angelia Mosley-Williams; John R Rice; David Caldwell Journal: Arthritis Care Res (Hoboken) Date: 2010-06 Impact factor: 4.794
Authors: Arthur J Barsky; David K Ahern; E John Orav; Yvonne Nestoriuc; Matthew H Liang; Ilana T Berman; Joshua R Kingsbury; Jennifer T Sy; Kathryn G Wilk Journal: Semin Arthritis Rheum Date: 2010-12 Impact factor: 5.532
Authors: N M Wulffraat; P J Haas; M Frosch; I M De Kleer; T Vogl; D M C Brinkman; P Quartier; J Roth; W Kuis Journal: Ann Rheum Dis Date: 2003-03 Impact factor: 19.103
Authors: Gülen Arslan; Linn Anne Brunborg; Livar Frøyland; Johan G Brun; Merete Valen; Arnold Berstad Journal: Lipids Date: 2002-10 Impact factor: 1.880
Authors: I M De Kleer; D M C Brinkman; A Ferster; M Abinun; P Quartier; J Van Der Net; R Ten Cate; L R Wedderburn; G Horneff; J Oppermann; F Zintl; H E Foster; A M Prieur; A Fasth; M A J Van Rossum; W Kuis; N M Wulffraat Journal: Ann Rheum Dis Date: 2004-10 Impact factor: 19.103